2022. A Phase 2 Study of Oral Difelikefalin for Moderate-to-Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT). SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s104. DOI:https://doi.org/10.25251/skin.6.supp.104.